Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 747,988 | 654,414 | 551,512 | 594,604 | 520,268 |
| Marketable Securities | 350,735 | 367,412 | 391,281 | 309,067 | 266,818 |
| Receivables | 57,762 | 54,211 | 61,815 | 39,370 | 73,657 |
| Inventories | 16,562 | 33,515 | 26,244 | 23,416 | 31,382 |
| Income taxes - deferred | 94,859 | 92,582 | 90,869 | 91,401 | 94,656 |
| TOTAL | $1,294,005 | $1,229,050 | $1,158,598 | $1,093,916 | $1,022,435 |
| Non-Current Assets | |||||
| PPE Net | 135,517 | 123,536 | 117,107 | 108,334 | 103,590 |
| Investments And Advances | 209,804 | 247,273 | 272,797 | 280,380 | 347,092 |
| Intangibles | 309,566 | 311,702 | 314,833 | 323,472 | 329,059 |
| Other Non-Current Assets | 36,508 | 27,559 | 21,052 | 25,125 | 23,792 |
| TOTAL | $691,395 | $710,070 | $725,789 | $737,311 | $803,533 |
| Total Assets | $1,985,400 | $1,939,120 | $1,884,387 | $1,831,227 | $1,825,968 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,444 | 9,773 | 10,887 | 5,621 | 7,874 |
| Accrued Expenses | 108,245 | 96,785 | 117,035 | 114,344 | 128,342 |
| TOTAL | $149,798 | $149,632 | $159,385 | $136,616 | $147,612 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 26,718 | 24,412 | 26,701 | 12,976 | 10,575 |
| Other Non-Current Liabilities | 31,248 | 27,430 | 23,238 | 22,975 | 23,354 |
| TOTAL | $48,435 | $45,400 | $39,652 | $38,745 | $38,220 |
| Total Liabilities | $198,233 | $195,032 | $199,037 | $175,361 | $185,832 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,878 | 108,674 | 108,736 | 110,429 | 111,808 |
| Common Shares | 107 | 109 | 110 | 111 | 112 |
| Retained earnings | 1,606,468 | 1,518,348 | 1,445,189 | 1,366,118 | 1,304,370 |
| Other shareholders' equity | 31,510 | 29,086 | 29,370 | 34,062 | 32,230 |
| TOTAL | $1,787,167 | $1,744,088 | $1,685,350 | $1,655,866 | $1,640,136 |
| Total Liabilities And Equity | $1,985,400 | $1,939,120 | $1,884,387 | $1,831,227 | $1,825,968 |